Bausch Health Companies (TSE:BHC) Announces Earnings Results

Bausch Health Companies (TSE:BHC) announced its earnings results on Wednesday. The company reported C($0.41) EPS for the quarter, FiscalAI reports. Bausch Health Companies had a negative net margin of 1.88% and a positive return on equity of 15.87%. The firm had revenue of C$6.62 billion for the quarter.

Bausch Health Companies Stock Down 4.7%

Shares of BHC opened at C$8.11 on Friday. The company’s fifty day moving average is C$9.11 and its two-hundred day moving average is C$9.26. Bausch Health Companies has a fifty-two week low of C$5.91 and a fifty-two week high of C$11.97. The company has a quick ratio of 0.58, a current ratio of 1.19 and a debt-to-equity ratio of -1,831.94. The firm has a market cap of C$3.00 billion, a PE ratio of 8.36, a price-to-earnings-growth ratio of 0.21 and a beta of 0.10.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Raymond James Financial upgraded shares of Bausch Health Companies to a “hold” rating in a report on Monday, December 15th. Barclays upgraded shares of Bausch Health Companies to a “hold” rating in a research note on Monday, December 8th. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock has an average rating of “Hold”.

About Bausch Health Companies

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.